We offer a wide range of treatments for spinal disorders and treat more brain tumors than any other center in New York. We have two designated Level 4 Comprehensive Epilepsy Centers that provide our complex epilepsy patients with the highest-level of medical and surgical care. Our mobile stroke units, equipped with the advanced technologies of an ED, continue to push the boundaries of comprehensive care for all patients.
Neurology and Neurosurgery
The Report on Clinical and Scientific Innovations in Neurology and Neurosurgery highlights the work of NewYork-Presbyterian physicians and scientists in glioblastoma, Alzheimer’s disease, movement disorders, epilepsy, and spinal care.
Facial Nerve Massage as Rescue Treatment for Hemifacial Spasm
CIDP: Gaining Insight on Treatment-Related Fluctuations
A Columbia neurologist specializing in peripheral neuropathy investigates the impact of IVIG treatment-related fluctuations on long-term chronic inflammatory demyelinating polyradiculoneuropathy that may help optimize therapy in real time.
Remote Blood Pressure Monitoring Reduces Recurrent Stroke Risk
Columbia neurologist develops and tests the feasibility of a home blood pressure monitoring system after stroke among Black and Hispanic patients living in underserved communities.
Augmented Reality: A Navigational Technology Finds its Niche in Spine Surgery
Weill Cornell Medicine’s neurosurgical team is among the first to use augmented reality technology to facilitate surgical flow in minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF) and in resection of intradural extramedullary tumors.
Novel Pathway Optimizes Assessment for Minor Stroke and TIA
Weill Cornell Medicine stroke neurologists develop a high-quality outpatient clinical pathway to expedite evaluation and treatment of patients presenting with a recent small stroke or transient ischemic attack.
Current State of Treatment for Intramedullary Spinal Tumors
Columbia spinal neurosurgeons provide insight and guidance on today’s surgical treatment for ependymomas and other intramedullary spinal cord tumors.
Advancing Gene Therapies for Neurodegenerative Diseases
A Weill Cornell Medicine neurosurgeon and renowned neuroscientist in the application of gene therapies discusses novel studies that hold tremendous promise for patients with debilitating neurological disorders.
The Power and Potential of Neurogenetics
Columbia neurology faculty with particular expertise in genetic foundations of neurological diseases discuss breakthroughs in diagnostic genetics for ALS and for epilepsy.
Stemming the Tide of Disc Degeneration After Microdiscectomy
Weill Cornell Medicine neurosurgeon and spine expert studies the safety and feasibility of injecting autologous stem cells at the time of lumbar surgery to prevent future disc degeneration.
Intracerebral Hemorrhage Outcomes: Comparing Vascular and Primary Causes
Weill Cornell Medicine neurologists compare primary intracerebral hemorrhage (ICH) versus ICH due to structural vascular lesions, which may be associated with lower mortality and improved outcomes.
Trigeminal Neuralgia: Maximal Pain Relief with Minimally Invasive Surgery
A Columbia neurosurgeon renowned for expertise in cranial nerve and skull base procedures provides relief for the incapacitating pain of trigeminal neuralgia through microvascular decompression.
Mitochondrial Diseases: Making Groundbreaking Progress in Uncommon Conditions
Columbia neurology faculty accelerate clinical and scientific advances for a very rare and complex set of neuromuscular diseases.
Laser Ablation: An Emerging Treatment for Drug-Resistant Epilepsy
Neurosurgeons at NewYork-Presbyterian/Columbia report on this minimally invasive approach that can be highly effective for select patients.
Post-Stroke Evaluation: How Safe is Transesophageal Echocardiography?
Weill Cornell Medicine neurologists, cardiologists, and pulmonary and critical care medicine specialists present findings on the risk of respiratory failure in patients undergoing TEE.
Spinal Cord Injury: Augmenting Function with Cervical Spine Mapping and Stimulation
Laboratory and clinical investigations are underway of novel approaches incorporating both brain and spine stimulation to improve recovery of patients with spinal cord injury with myelopathy.
A Model Way to Detect Delayed Cerebral Ischemia
Columbia University faculty at NewYork-Presbyterian Hospital developed a classification model to alert clinicians to delayed cerebral ischemia, helping to provide an opportunity to reduce neurological injury following an aneurysmal subarachnoid hemorrhage.
The Brain: A New Normal After Menopause
Using multi-modality neuroimaging, Weill Cornell Medicine neurology faculty at NewYork-Presbyterian Hospital reveal menopause is a dynamic neurological transition that significantly impacts brain structure, connectivity, and the metabolic profile during midlife endocrine aging of the female brain.
A New Application for Focused Ultrasound
NewYork-Presbyterian Hospital’s neurosurgeons are applying their expertise in focused ultrasound to penetrate the blood-brain barrier and provide new pathways for drug delivery to extend and improve life for patients with glioblastoma and Alzheimer’s disease.
A Multidimensional Treatment Approach to Spinal Tumors
Neurosurgeons, interventional neuroradiologists, and neuro-oncologists at NewYork-Presbyterian Hospital are advancing care for benign and malignant spinal tumors through a comprehensive and multidisciplinary strategic approach.
Taking Spine Surgery to New Heights
At NewYork-Presbyterian Hospital, patients find world-renowned spine surgeons representing the fields of neurosurgery and orthopedic surgery. These top specialists offer extraordinary expertise and experience with leading-edge surgical techniques, from endovascular options to the most complex spinal deformity surgeries.
Confronting the Challenges of Glioblastoma Treatment
Neurosurgeons and neuro-oncologists at NewYork-Presbyterian Hospital are pioneering new methods to address two major hurdles to successful treatment – getting past the blood-brain barrier to deliver drugs and incorporating immunotherapy in a cancer that is particularly resistant to this form of treatment.
Multiple Sclerosis: Rethinking How It Begins and Why It Progresses
Physician-scientists at NewYork-Presbyterian/Columbia and NewYork-Presbyterian/Weill Cornell are pursuing research that is yielding a better understanding of what triggers multiple sclerosis, how the disease progresses, and furthers therapeutic options.
Neurosurgeons Advance Applications of Minimally Invasive Techniques for Epilepsy
Patients with refractory epilepsy are finding new hope at NewYork-Presbyterian/
Innovating Minimally Invasive Access to the Brain and Spine
Neurosurgeons at NewYork-Presbyterian/
Cerebral Organoids: Personalizing Glioblastoma Treatment
A neuro-oncologist at NewYork-Presbyterian/
A Renowned Center for Neurology Care and Research
As the destination of choice for patients with neurologic diseases and disorders, NewYork-Presbyterian/
Addressing the Ongoing Challenge of Glioblastoma
Glioblastoma is the most prevalent and most aggressive malignant brain tumors in adults. The neurospecialists at NewYork-Presbyterian/
Pushing the Boundaries for Brain Tumor Treatment
The neuro-oncologists at the Weill Cornell Brain and Spine Center are pushing the boundaries of treatment for patients with brain tumors by using the newest treatment modalities, including awake mapping, imaging techniques, and microsurgery.
The Gamma Knife Evolution Continues
In its 50-year history, the Gamma Knife has proven to be one of the most significant noninvasive technologies available to treat benign and malignant brain lesions and disorders.
Study Clarifies ApoE4’s Role in Dementia
In a study published in journal Nature Communications, researchers at Weill Cornell Medicine identify a protein that increases the risk of cognitive impairment.
Alzheimer’s and Prevention: Who Would Have Thought?
A family history of Alzheimer’s disease has been the driving force for a NewYork-Presbyterian/
A Commitment to Conquering ALS
At the Eleanor and Lou Gehrig ALS Center at NewYork-Presbyterian/
HIFU: Heralding New Hope for Movement Disorders
Newsletters for Medical Professionals
2022 Issue 2
- Post-Stroke Evaluation: How Safe is Transesophageal Echocardiography?
- Laser Ablation: An Emerging Treatment for Drug-Resistant Epilepsy
2022 Issue 1
- Major Grant Propels Research in Early Stage Parkinson’s Disease
- Promising ALS Therapy Moves Closer to the Clinic
2021 Issue 3
2021 Issue 2
2021 Issue 1
- A Wake-Up Call for Addressing Sleep Deprivation
- Dr. E. Sander Connolly Jr. Named Neurosurgeon-in-Chief at Columbia
- Donald O. Quest, MD, Honored for Lifetime of Service
2020 Issue 1
- MMA Embolization: A Novel Approach to Managing Subdural Hematoma
- Dr. Mitchell Elkind Named President of American Heart Association
- New Evidence of Cognition in Patients with Severe Brain Injury
- Validating an MRI Measure of Pathology in Alzheimer’s Disease
- Advancing Alzheimer’s Disease Research through Multi-omics Data
- Strategic and Multipronged Approaches to Spinal Tumors
- Dr. Cigdem Akman Leads Child Neurology at Columbia
- Study Clarifies ApoE4’s Role in Dementia
- Targeting Endosomal Trafficking in Alzheimer’s Disease
- Alzheimer’s and Prevention: Who Would Have Thought?
- HIFU: Heralding New Hope for Movement Disorders
- A Commitment to Conquering ALS
- NIH Director’s Pioneer Award Bestowed on Weill Cornell Researcher
- Comprehensive Programs Address Brain and CNS Metastases
- Multidisciplinary Central Nervous System Metastases Clinic
- Brain Metastases Clinic
- Expanding Expertise in Neurology and Neurosurgery
- Making Strides in the Treatment of Hemorrhagic Stroke
- Mobile Stroke Treatment Unit Hastens Early Intervention